lution ** for patients with oilcans rash or pain at Day 28 .3s any for Pit purposes. Data mduded n final analysis 9 9 EFTA00506078 EPB-348 met Phase 2b primary antiviral endpoint of time-to-complete crusting versus Valacyclovir • EPB-348 once-a-day was statisticallynon-inferior or ;superior to va